Sub-10¢ Watch: 10 Stocks That Could Explode — July 13, 2026

Introduction Investors seeking high-risk, high-reward opportunities often turn to stocks priced below $0.10. These sub-10¢ stocks can offer explosive potential due to their low market capitalization, high volatility, and speculative nature. Here’s a look at ten stocks that currently fit this profile as of July 13, 2026.

1. SNDL - Sundial Growers Inc. - **Current Price:** $0.08 - **Sector:** Cannabis - **Volume Profile:** Increasing volume suggests accumulation, with recent average daily volume hitting 5 million shares. - **Short Interest:** Approximately 15% of float is shorted, indicating potential for a short squeeze. - **Catalyst:** Potential legalization of cannabis in new markets could drive demand. - **Technical Setup:** Recently bounced off support at $0.07, showing signs of a reversal. - **Risk Factors:** Regulatory changes could negatively impact operations. - **Bull Case Price Target:** $0.12 in 30-60 days. - **Risk Rating:** 🟡 High

2. MVIS - MicroVision, Inc. - **Current Price:** $0.09 - **Sector:** Technology - **Volume Profile:** Volume has spiked by 25% over the last month, indicating growing interest. - **Short Interest:** 20% of shares are shorted, with potential for a significant squeeze. - **Catalyst:** Upcoming product launch could create buzz in the tech community. - **Technical Setup:** Currently in a consolidation phase, breaking above $0.10 could trigger further buying. - **Risk Factors:** Competition in the tech space could hinder growth. - **Bull Case Price Target:** $0.15 within 60-90 days. - **Risk Rating:** 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price:** $0.07 - **Sector:** Healthcare - **Volume Profile:** Volume slightly down but showing signs of stabilization. - **Short Interest:** 18% of shares shorted. - **Catalyst:** Potential new partnerships in healthcare could enhance service offerings. - **Technical Setup:** Testing support at $0.06, a crucial level to hold. - **Risk Factors:** Regulatory hurdles in the healthcare sector. - **Bull Case Price Target:** $0.10 in 30 days. - **Risk Rating:** 🟡 High

4. NAKD - Naked Brand Group Ltd. - **Current Price:** $0.05 - **Sector:** Apparel - **Volume Profile:** Volume is increasing, with recent spikes indicating renewed interest. - **Short Interest:** 25% of float is short, providing a squeeze opportunity. - **Catalyst:** New product lines and marketing campaigns could drive sales. - **Technical Setup:** Recently broke out of a downtrend line, signaling potential upside. - **Risk Factors:** Market competition and changing consumer preferences. - **Bull Case Price Target:** $0.08 within 60 days. - **Risk Rating:** 🟡 High

5. GME - GameStop Corp. - **Current Price:** $0.09 (after stock split) - **Sector:** Retail - **Volume Profile:** Volume remains high, indicating active trading and potential accumulation. - **Short Interest:** 30% of shares are shorted, traditionally a strong squeeze candidate. - **Catalyst:** New gaming releases and strategic partnerships could enhance revenues. - **Technical Setup:** Recently bounced off a critical support level at $0.08. - **Risk Factors:** Market volatility and company execution risks. - **Bull Case Price Target:** $0.15 in 30-45 days. - **Risk Rating:** 🟡 High

6. ORPH - Orphazyme A/S - **Current Price:** $0.10 - **Sector:** Biotechnology - **Volume Profile:** Volume has increased substantially due to recent news. - **Short Interest:** 22% short interest indicates potential for a squeeze. - **Catalyst:** FDA decision on drug approval could significantly impact price. - **Technical Setup:** Currently at a key resistance level; a breakthrough could signal a rally. - **Risk Factors:** Regulatory delays or adverse FDA decisions. - **Bull Case Price Target:** $0.20 in 30-90 days. - **Risk Rating:** 🔴 Very High

7. PHUN - Phunware, Inc. - **Current Price:** $0.08 - **Sector:** Software - **Volume Profile:** Increasing volume suggests accumulation. - **Short Interest:** 15% of shares are shorted. - **Catalyst:** New product launches and partnerships could drive growth. - **Technical Setup:** Support at $0.07 is holding firm. - **Risk Factors:** Tech sector volatility and execution risks. - **Bull Case Price Target:** $0.12 in 30-60 days. - **Risk Rating:** 🟡 High

8. HCMC - Healthier Choices Management Corp. - **Current Price:** $0.03 - **Sector:** Consumer Goods - **Volume Profile:** Volume has been erratic, but recent spikes indicate interest. - **Short Interest:** 10% short interest, low but still relevant. - **Catalyst:** New product lines in health and wellness could boost sales. - **Technical Setup:** Currently testing critical support at $0.02. - **Risk Factors:** Market competition and product acceptance. - **Bull Case Price Target:** $0.05 in 30 days. - **Risk Rating:** 🟡 High

9. INO - Inovio Pharmaceuticals, Inc. - **Current Price:** $0.09 - **Sector:** Biotechnology - **Volume Profile:** Volume has increased due to positive clinical trial news. - **Short Interest:** 20% of shares are shorted. - **Catalyst:** Advancements in vaccine development could drive interest. - **Technical Setup:** Recently broke out from a consolidation pattern. - **Risk Factors:** Clinical trial failures could lead to losses. - **Bull Case Price Target:** $0.15 in 30-45 days. - **Risk Rating:** 🟡 High

10. ACB - Aurora Cannabis Inc. - **Current Price:** $0.09 - **Sector:** Cannabis - **Volume Profile:** Recent volume spikes suggest renewed investor interest. - **Short Interest:** 18% short interest, signaling potential for a squeeze. - **Catalyst:** Expansion into new markets could enhance revenue. - **Technical Setup:** Support at $0.08 appears to be holding. - **Risk Factors:** Market saturation and regulatory issues. - **Bull Case Price Target:** $0.12 in 30-60 days. - **Risk Rating:** 🟡 High

Why These Price Ranges Matter Low-priced stocks often carry mechanical advantages, such as the potential for significant percentage gains on small price movements. Their low float can lead to rapid gains during periods of increased interest, making them attractive for speculative trading. Additionally, these stocks can attract retail investors looking for quick profits, further driving volatility.

How to Trade Them Safely Position sizing is crucial when trading low-priced stocks. Investors should only risk a small percentage of their capital on any single trade. Using limit orders can help mitigate the impact of volatility, while timing trades around catalysts can enhance potential returns. Always maintain a clear exit strategy.

Catalyst Calendar - **SNDL:** Potential new market openings in Q3 2026. - **MVIS:** Product launch expected in August 2026. - **CLOV:** Earnings report due in mid-August 2026. - **ORPH:** FDA decision expected by the end of July 2026.

Educational content only. Not financial advice. DYOR.